Latest news with #KareemShahin
Al Etihad
01-05-2025
- Health
- Al Etihad
M42, Reem Hospital to launch ‘Nafas' mental health platform
1 May 2025 12:55 ABU DHABI (WAM)M42's Digital Health Solution (DHS) platform, represented by Abu Dhabi Health Data Services (ADHDS), and Reem Hospital, have entered a joint venture (JV) agreement to launch Nafas, a pioneering mental health platform and service dedicated to the residents and citizens of Abu agreement was signed by the Chief Executive Officer of M42's Digital Health Solution platform, Kareem Shahin, and the Chairman of Reem Hospital Zaid Al - meaning 'breathing' in Arabic - is envisioned to be a pioneering mental health platform for the Emirate of Abu Dhabi. This collaboration combines the established digital health expertise of ADHDS with the end-to-end clinical expertise of Reem Hospital in order to offer comprehensive mental health services to the platform will leverage ADHDS' robust digital health technology solutions, enabling Reem Hospital's clinical capabilities to provide a holistic approach to mental health care that is easily accessible to the mission of offering accessible, high-quality and discreet mental health support, Nafas will serve as a comprehensive resource for mental health services and solutions across Abu will bring together a full spectrum of mental health support in one seamless platform. From secure one-to-one virtual therapy sessions with easy booking and reminders, to round-the-clock chat support and a rich library of multilingual content, Nafas will offer individuals the tools they need to navigate their mental will play a transformative role in Abu Dhabi's mental health landscape, removing barriers to care and fostering a safe, supportive environment, enabling more people to seek the help they need, when and where they need it on the venture, Shahin said, 'Nafas will provide a comprehensive mental health platform that empowers residents and citizens of Abu Dhabi to take control of their mental well-being in a secure and convenient environment.""Using the UAE as a launchpad, our ambition is to expand this platform internationally, reaching a wider user base and supporting people all around the world to combat mental health conditions," he said. Al Siksek commented, 'Mental health is a key component of overall health, and through Nafas, we are excited to offer accessible, high-quality mental health services that will benefit all members of our community. This partnership represents a significant step forward in advancing mental health care in Abu Dhabi and beyond.'
Zawya
01-05-2025
- Health
- Zawya
M42, Reem Hospital to launch ‘Nafas' mental health platform
ABU DHABI - M42's Digital Health Solution (DHS) platform, represented by Abu Dhabi Health Data Services (ADHDS), and Reem Hospital, have entered a joint venture (JV) agreement to launch Nafas, a pioneering mental health platform and service dedicated to the residents and citizens of Abu Dhabi. The agreement was signed by the Chief Executive Officer of M42's Digital Health Solution platform, Kareem Shahin, and the Chairman of Reem Hospital Zaid Al Siksek. Nafas - meaning 'breathing' in Arabic - is envisioned to be a pioneering mental health platform for the Emirate of Abu Dhabi. This collaboration combines the established digital health expertise of ADHDS with the end-to-end clinical expertise of Reem Hospital to offer comprehensive mental health services to the community. The platform will leverage ADHDS' robust digital health technology solutions, enabling Reem Hospital's clinical capabilities to provide a holistic approach to mental health care that is easily accessible to patients. With the mission of offering accessible, high-quality and discreet mental health support, Nafas will serve as a comprehensive resource for mental health services and solutions across Abu Dhabi. Nafas will bring together a full spectrum of mental health support in one seamless platform. From secure 1-to-1 virtual therapy sessions with easy booking and reminders, to round-the-clock chat support and a rich library of multilingual content — Nafas will offer individuals the tools they need to navigate their mental well-being. It will play a transformative role in Abu Dhabi's mental health landscape, removing barriers to care and fostering a safe, supportive environment, enabling more people to seek the help they need — when and where they need it most. Commenting on the venture, Shahin said, 'Nafas will provide a comprehensive mental health platform that empowers residents and citizens of Abu Dhabi to take control of their mental well-being in a secure and convenient environment. "Using the UAE as a launchpad, our ambition is to expand this platform internationally, reaching a wider user base and supporting people all around the world to combat mental health conditions.' Al Siksek commented, 'Mental health is a key component of overall health, and through Nafas, we are excited to offer accessible, high-quality mental health services that will benefit all members of our community. This partnership represents a significant step forward in advancing mental health care in Abu Dhabi and beyond.'
Al Etihad
22-04-2025
- Business
- Al Etihad
Abu Dhabi Health Data Services, Syndesis Health collaborate to advance AI-driven genomic analytics, drug discovery
22 Apr 2025 17:27 ABU DHABI (WAM)Abu Dhabi Health Data Services (ADHDS), part of M42's Digital Health Solutions (DHS) platform, has announced a collaboration with Syndesis Health, one of the world's largest holders of phenotype data, encompassing over 70 million patient term sheet was signed by Kareem Shahin, CEO of M42's Digital Health Solutions platform and Josh Sutton, CEO of Syndesis Health, reinforcing Abu Dhabi's position as a global hub for digital health collaboration brings together Syndesis Health's extensive phenotype database and ADHDS's cutting-edge digital health infrastructure to drive advancements in AI-powered genomic analytics, precision medicine, and drug combining real-world data with advanced artificial intelligence, the collaboration aims to accelerate innovation in clinical decision support and pharmaceutical research, ultimately improving treatment pathways for patients partnership will focus on three key areas:- Commercialising phenotype data to support global pharmaceutical, biotech, and academic research- Developing AI-driven predictive models that enable personalised and data-driven healthcare while maintaining strict compliance with international data governance standards-Enhancing genomic analytics to improve prescription safety and reduce adverse drug reactions through AI-powered pharmacogenomicsBy leveraging their complementary capabilities, the parties have signed a term sheet outlining their intent to establish a joint venture focused on generating valuable insights to accelerate drug development, enhance patient outcomes, and support the advancement of the healthcare infrastructure. This potential collaboration aligns with the Abu Dhabi's vision of positioning itself as global leader in digital health and biomedical Shahin, CEO of M42's Digital Health Solutions platform, emphasised the significance of the partnership, stating, "This collaboration represents a major step forward in harnessing real-world data and AI to transform healthcare. By integrating Syndesis Health's vast phenotype dataset with our digital health expertise, we are opening new frontiers in genomic analytics and drug discovery."Josh Sutton, CEO of Syndesis Health, added, "The collaboration between Syndesis Health and ADHDS will generate groundbreaking insights that accelerate pharmaceutical innovation and improve patient outcomes. Together, we are setting new benchmarks for AI-driven healthcare solutions." With a shared commitment to advancing global healthcare through data-driven innovation, this partnership marks a significant milestone in the evolution of precision medicine and AI-powered drug discovery.
Zawya
22-04-2025
- Business
- Zawya
Abu Dhabi Health Data Services and Syndesis Health announce collaboration
Abu Dhabi, UAE – Abu Dhabi Health Data Services (ADHDS), part of M42's Digital Health Solutions (DHS) platform, has announced a collaboration with Syndesis Health, one of the world's largest holders of phenotype data, encompassing over 70 million patient profiles. The term sheet was signed by Kareem Shahin, CEO of M42's Digital Health Solutions platform and Josh Sutton, CEO of Syndesis Health, reinforcing Abu Dhabi's position as a global hub for digital health innovation. This collaboration brings together Syndesis Health's extensive phenotype database and ADHDS's cutting-edge digital health infrastructure to drive advancements in AI-powered genomic analytics, precision medicine, and drug discovery. By combining real-world data with advanced artificial intelligence, the collaboration aims to accelerate innovation in clinical decision support and pharmaceutical research, ultimately improving treatment pathways for patients worldwide. The partnership will focus on three key areas: Commercializing phenotype data to support global pharmaceutical, biotech, and academic research. Developing AI-driven predictive models that enable personalized and data-driven healthcare while maintaining strict compliance with international data governance standards. Enhancing genomic analytics to improve prescription safety and reduce adverse drug reactions through AI-powered pharmacogenomics. By leveraging their complementary capabilities, the parties have signed a term sheet outlining their intent to establish a joint venture focused on generating valuable insights to accelerate drug development, enhance patient outcomes, and support the advancement of the healthcare infrastructure. This potential collaboration aligns with the Abu Dhabi's vision of positioning itself as global leader in digital health and biomedical research. Kareem Shahin, CEO of M42's Digital Health Solutions platform, emphasized the significance of the partnership, stating: "This collaboration represents a major step forward in harnessing real-world data and AI to transform healthcare. By integrating Syndesis Health's vast phenotype dataset with our digital health expertise, we are opening new frontiers in genomic analytics and drug discovery." Josh Sutton, CEO of Syndesis Health, added: "The collaboration between Syndesis Health and ADHDS will generate groundbreaking insights that accelerate pharmaceutical innovation and improve patient outcomes. Together, we are setting new benchmarks for AI-driven healthcare solutions." With a shared commitment to advancing global healthcare through data-driven innovation, this partnership marks a significant milestone in the evolution of precision medicine and AI-powered drug discovery. About Abu Dhabi Health Data Services LLC (ADHDS) Abu Dhabi Health Data Services (ADHDS), at the core of M42's Digital Health Solutions Platform (DHS), is a premier digital healthcare solutions company serving as a strategic catalyst for advancing the healthcare ecosystem in Abu Dhabi and beyond. ADHDS digitally empowers health by championing innovative solutions to elevate the quality of care, expand access, optimise costs, and unleash efficiencies on a national, regional, and global scale. Harnessing the power of data and technology, ADHDS drives transformative change across the healthcare eco-system and makes a lasting impact on the communities they serve. ADHDS was established in 2018 as a Private-Public Partnership (PPP) with the Department of Health Abu Dhabi (DOH) to build and operate Malaffi, the trailblazing Abu Dhabi Health Information Exchange (HIE). Following the successful delivery of Malaffi, as one of the fastest rolled out and most advanced HIEs globally, ADHDS has become renowned for successfully delivering major national digital healthcare transformational projects, acting as a critical link between regulators, governments, healthcare providers, biopharma companies, and patient communities. Media Contact Mohammed Al Naseri About M42 M42 is a global health champion powered by artificial intelligence (AI), technology and genomics to advance innovation in health for people and the planet. Headquartered in Abu Dhabi, M42 combines its specialized, state-of-the-art facilities with integrated health solutions like genomics and biobanks, and harnesses advanced technologies to deliver precise, preventive and predictive care, to impactfully disrupt traditional healthcare models and positively impact lives globally. Established in 2022, following the coming together of G42 Healthcare and Mubadala Health, M42 has more than 480 facilities in 26 countries and over 20,000 employees. M42 includes renowned healthcare providers including Cleveland Clinic Abu Dhabi, Danat Al Emarat, Diaverum, Imperial College London Diabetes Centre, Sheikh Sultan bin Zayed Hospital, and Moorfields Eye Hospital Abu Dhabi. As well as operating the Emirati Genome Programme, M42 runs Abu Dhabi BioBank and Abu Dhabi Health Data Services (ADHDS), a global tech-enabled healthcare company operating Malaffi. For media inquiries or interview opportunities, please contact: Mazar Masud Senior Director, Global Corporate Communications, M42 E: mmasud@ Asala Fadda Senior Manager, Group Marketing & Communications, M42 E: afadda@ About Syndesis Health Syndesis is the data and technology catalyst to a multi-continent network of healthcare and life sciences organizations. Its primary aim is to enhance global health outcomes and equity through its secure data platform, Syntium, and the Syndesis Health Network, a member community promoting research collaboration, information sharing, and access to common tools. For media inquiries or interview opportunities, please contact: Hans Godfrey E:
Al Etihad
18-04-2025
- Business
- Al Etihad
Abu Dhabi to launch 'Silicon Valley for AI and Healthcare' Innovation Hub
18 Apr 2025 19:49 ABU DHABI (ALETIHAD)Abu Dhabi Health Data Services (ADHDS), a cornerstone of M42's Digital Health Solutions (DHS) platform, announced on Thursday a strategic partnership to stablish a pioneering Innovation Hub in Abu in collaboration with SRI International (SRI), a research and development leader based in Silicon Valley, USA, and VantageBridge Partners, a private equity firm headquartered in the Abu Dhabi Global Market (ADGM), the facility aims to position Abu Dhabi as a global epicentre for AI and healthcare Innovation Hub will serve as a catalyst for digital health transformation, fostering the growth of startups, driving cutting-edge research, and facilitating the exchange of intellectual property and global during Abu Dhabi Global Health Week (ADGHW), the partnership was formalised through an agreement signed in the presence of Mansoor Al Mansoori, Chairman of the Department of Health – Abu Dhabi (DoH), and Hasan Jasem Al Nowais, Managing Director and Group Chief Executive Officer of signing ceremony featured Kareem Shahin, CEO of M42's Digital Health Solutions platform, Peter Marcotullio, Senior Vice President of Commercialisation at SRI, and Alain Baron, Founder and CEO of VantageBridge integrating ADHDS's advanced healthcare data infrastructure with SRI's unparalleled R&D capabilities and VantageBridge's expertise in securing investment and market access, the partnership will create a robust ecosystem that attracts top-tier talent, fuels economic diversification, and positions Abu Dhabi at the forefront of AI-driven healthcare Partners has committed to leading commercialisation activities to support significant investment, while SRI will establish an exclusive relationship with ADHDS for healthcare and AI initiatives across the Middle East, Turkey, and Africa (META) Al Mansoori, Chairman of the Department of Health – Abu Dhabi, emphasised, 'This partnership reflects our unwavering commitment to building a world-class healthcare ecosystem powered by innovation and global collaboration. The Innovation Hub will play a pivotal role in advancing research, attracting exceptional talent, and delivering transformative health solutions that extend far beyond Abu Dhabi, benefiting the region and the world.'Peter Marcotullio, Senior Vice President of Commercialisation at SRI, added, 'We are thrilled to partner with ADHDS and VantageBridge to create this Innovation Hub in Abu Dhabi. By combining SRI's expertise in research and technology with ADHDS's vision for healthcare transformation and VantageBridge's investment acumen, we are poised to unlock groundbreaking innovations that will redefine the global healthcare landscape and improve lives worldwide.'Kareem Shahin, CEO of M42's Digital Health Solutions platform, highlighted, 'This collaboration with SRI and VantageBridge is a landmark moment in our mission to build a future ready healthcare ecosystem. The Innovation Hub will serve as a global platform for pioneers and entrepreneurs, harnessing the power of AI to address tomorrow's healthcare challenges. Abu Dhabi is now positioned to lead the world in AI-driven healthcare innovation, amplifying our impact on health outcomes globally.'Alain Baron, Founder and CEO of VantageBridge Partners, underscored, 'This strategic partnership aligns perfectly with the Department of Health's vision to establish Abu Dhabi as a global leader in health innovation. By fostering investment opportunities and accelerating research, we are not only addressing critical healthcare challenges but also creating a lasting legacy of technological progress, economic growth, and enhanced wellbeing across the region.' This collaboration aligns with Abu Dhabi's broader vision to become a world-class destination for health innovation and a hub for life sciences, reinforcing its role as a leader in the global healthcare sector.
